Member Info for HarChris

What is with this obsessed with unrealistic government targets that are never, ever met?

That's a bit frustrating, I was going to buy the Sunday Times today hoping to see Richard's big friendly face plastered across a double page spread.

Monday? Absolutely no idea.

This time next year? 5.70

Wasn't it gggg saying this earlier?

In the ST I can't think of anything that could tank the share price, the worst case scenario is a lack of news. On the other hand there's a number of things that could excite the market with even the chance of EUA in the foreseeable future pre p3 readout.

With a conservative target of £10 by Numis it's not hard to imagine interest growing considerably from here on out...

Take your questions to the SNG board, they'll happily answer all the questions you just posed.

Please please let this be the last post on the topic.

I'm sorry Wbernard but that's rubbish. The sng forum is an extremely informed bb with researchers that are well ahead of the market and a couple that have direct contact with the ceo. The fact that you are trying to compare dexamethasone that is only used at very late stage illness with sng (which is now being looked at for at home early stage, oxygenated patients and late stage) just goes to show that it's in fact you that is not very clued up.

That's fine, this isn't the sng board but no need to spread misinformation here. I'll leave it at that and get back to the mighty novacyt!

And I'm giving your grammar a 2.6

I'm not sure how you come to that conclusion after how successful the phase 2 trial was?
How would you have designed the p3 Wbernard? Less countries, less red tape? It's been adapted to suit the FDA following the fast track designation status it was awarded. The company is founded by some of the most respected scientists in the UK including the eminent Sir Stephen Holgate.

It's up 1500% since this time last year so I hope you haven't been warning people throughout that time!

Unsure if this is of much relevance right now but I'll post in case: https://www.cityam.com/exclusive-government-scraps-antibody-tests-at-nhs-sites/

Matml, great post but once again and for the final time, the discussion over £10 (basically Numis' target) was a purely hypothetical one. It was would a T/O offer of £10 on the table Monday morning be accepted and the answer is almost certainly yes.

NOT following successful p3. I think more or less everyone agrees that this company has the potential to be worth a hell of a lot more than £2b for all the reasons you've just outlined.

It was me that mentioned £10 and it was based on a hypothetical offer landing of a tenner on Monday, not following successful P3. Whilst many deny they would accept that offer I can't imagine Polar refusing their £200m return risk-free.

So there was Prop, that other one was before I joined the party. My first buy was April 1st and it was no April fools!

I agree with most of your comments on the rampers,
***********************
This couldn't be further from the truth. There are at most three posters that throw out wild baseless predictions but even with those posters it seems to be coming from a good place, not a cynical pump and dump strategy. It is trolls, derampers and just general nuisances that damage this board in their dozens...

What on earth are you talking about?? And who on earth recommended your post??
We had about 6 RNSs mid March over a 2-3 week period and went from around 110 to 500!!
I remember it well..
******************
Your memory has served you well but your comprehension has served you less well on this occasion :)

There was one notable rns that landed intraday at 16.15, not one notable rns full stop. He didn't mix up the releases, they have almost all been 07.00 apart from one that caused a massive reaction on here just before close of business in I think April.

HarChris a Binary Bet ranges from 0 to 100 - so where do you place your comment of not such a Binary Bet? What is your figure? Be specific buddy
+++++++++++++++++
You know what I meant by 'not a binary bet', and so will Porky. Not the bookmaking definition, I meant it's not a coin flip.

Imo come May the share price will be somewhere between 40p and £20. But if you get in at £1.60 then you’ll very likely get a chance to take some off the table around £3 when the news we are all waiting for starts filtering through, so in that sense this isn’t quite the binary bet you seem to think it is.

Porky, as an ncyt friend I'll give you the best I have to offer although there are holders here far intelligible than me.

I first bought here in March in what was without doubt a punt. I wanted to be in a biotech with a covid-related drug and truth be told I probably went with synairgen based on the trust and respect I had for a few posters on this bb but also the team at the top of synairgen (and I'm a Soton Uni alumni!). This was my first ever AIM buy and I got a bit jittery waiting for p2 results and ended up selling a third of my holding the Friday before the Monday that was! The news we all hoped for landed (and some!) and the rest is history. As it happens I managed to buy them back at 08:05 paying a mere 100% premium!

Since then it's been an almighty ride. I have learnt that it's absolutely essential to ignore the share price and focus on the research and whether the investment case has actually changed meaningfully following big sp swings. When the vaccine news landed I took the gamble to sell on the news and then begin building what for me is now a potentially lifechanging holding between 77p and 90p.

Today the investment case has never been stronger. Even just a few months ago I would be questioning if I was being incredibly credulous and overly attached to this company. How can I be so sure that on a strong p3 result, which is without doubt likely, we will be 600%+ higher than where we are now when the share price is struggling to hold above 160p? Surely these shares would be snapped up and gone at this level and we'd be looking at £3 minimum? But I'm sure I'm not kidding myself. This is an absolutely unbelievable opportunity.

Looking back this could well have gone wrong. If Sars CoV 2 turned out to be mutating at a much slower rate with little chance of vaccine-evading mutations we might not be looking at such a compelling investment case. If a couple of other drugs had turned out to be highly effective treatments and as versatile as sng001 we might not be looking at such a compelling investment case. If the virus had managed to be much more easily contained globally we might not be clamouring for effective treatments like we are now... but none of these are what we are faced with as of today.

As for sng001 the recent findings related to the ACE2 protein significantly improve the chances of a successful phase 3 result, and possibly convincing enough to be given emergency approval in just five or six weeks time.

Go through this bb as much as you can this weekend. Pay particular attention to posts from the likes of pmjh, Oxford12, Ghia, AnthonyW, Docdaneeka, SeaBoy. See if you can find the recent webinars and presentations from synairgen and Richard Marsden and watch the youtube videos with Proactive.

Ask yourself this, can you afford to lose that £50k? Not would it be a big blow but can I afford to lose it? If yes I think this is an incredible opportunity at this price.

Remember around the 200’s when Graeme bombarded us with RNS’s mixing up the releases at either 7am or 3:30.. I’m sure he did around 4-5 in a row!!
********************
I actually think there was one, literally just the one notable rns that landed at 16.15 in about March or April time and then for four months SH3 raised the spectre of another intraday rns!

£10 would be absolutely life changing for me with what I'm holding so would struggle to turn it down knowing there are still some risks ahead. If this got to £3 and I could take some off the table at a massive profit I'd be ready to turn down a tenner for sure!